2026 Asia Bioassay Conference
Incheon, South Korea | November 4-6, 2026
Registration
Registration is not yet open for our 2026 Asia Bioassay Conference. Check back soon!
3-Day Event
(In-Person Only)
November 4-6, 2026
2-Day Event
(In-Person or Virtual)
November 5-6, 2026
Group Discounts (only applicable to Industry tickets):
Quick Links
November, 2026
Incheon, South Korea
Hybrid Conference
Deadlines
Abstract Submission: March 6, 2026
Poster Submission: Oct. 14, 2026
Next Price Increase: TBA
Registration Closes:
In-person closes Oct. 23, 2026
Virtual closes Oct. 30, 2026








Draft Agenda
Our 2026 Asia Bioassay Conference agenda is coming soon! Abstracts are due by March 6th to be considered for a podium talk. Check the agenda for updates as we finalize our schedule.
Note: The official language of the conference is English. No simultaneous translation will be provided.
Suggested Topics:
- Handling legal and biological aspects for cell lines of cell based assays
- Product specific potency assays – for classic, complex and novel products
- Validation of Potency Assays
- Regulatory Frameworks for Potency BioAssays: Implementation of Regulatory Guidances in Potency BioAssays, Expectations for bioassay during the licensure process,
- Developing and Maintaining in-house Reference Materials for Potency Assays
- The ins and outs of assessing equivalence for BioSimilar Products
- AI and Automation in Potency Labs
- What are the QA requirements for BioAssays?
- Evoloving Statistical Tools for Relative Potency Assays: DOE, Bayesian Statistics, Assessing Dose Response Curve Similarity, Use of Outlier Analysis
- BioAssays for Complex Proteome and Cell-based Products
- Developing and Maintaining Critical Reagents for Potency BioAssays
- Not all potency bioassays are relative potency assays, discussions of what these methods are and how they are developed.
- Stability Indicating Properties of Potency Assays
Don’t see your topic listed above? Submit anyway! Those presentations often end up being our most loved!
Participating Companies:
- List Coming Soon
Hotel Information
A room block is being prepared for the 2026 Hybrid Asia Bioassay Conference. Check back for updates!
2026 Asia Bioassay Exhibitors
2026 Planning Committee
Gaurav Agrawal
Eurofins
Frank Fan
Promega Corporation
Chaohong (Mary) Hu
Independent Consultant
Hoosung Hwang
BioAnalytix Lab
Xu-Rong Jiang
Bristol Myers Squibb
Jun Kim
BioAnalytix Lab
Laureen Little
BEBPA
Jun Park
Korea Health Industry Development Institute
SungAe Park
Independent Consultant
Ayumi Takayanagi
Chugai Pharmaceutical
Andrew Thomson
GreyRigge Associates
Yukina Umemoto
Chugai Pharmaceutical